Scarica l'app Stockscreener
118.42
1.29%
1.51
Dopo l'orario di chiusura:
118.43
0.01
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$116.91
Aprire:
$117.49
Volume 24 ore:
442.40K
Relative Volume:
0.65
Capitalizzazione di mercato:
$3.40B
Reddito:
$267.23M
Utile/perdita netta:
$-83.50M
Rapporto P/E:
-38.08
EPS:
-3.11
Flusso di cassa netto:
$-59.99M
1 W Prestazione:
-6.62%
1M Prestazione:
-2.43%
6M Prestazione:
+20.49%
1 anno Prestazione:
+94.83%
Intervallo 1D:
$116.85
$124.84
Intervallo di 1 settimana:
$115.00
$129.35
Portata 52W:
$54.14
$136.00
Genedx Holdings Corp Stock (WGS) Company Profile
Nome
Genedx Holdings Corp
Settore
Industria
Telefono
888-729-1206
Indirizzo
333 LUDLOW STREET, STAMFORD
Confronta WGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
118.42 | 3.51B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-05-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-10 | Iniziato | Craig Hallum | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
Mostra tutto
Genedx Holdings Corp Borsa (WGS) Ultime notizie
Cathie Wood’s ARK buys Genedx, sells Quantum-Si stock By Investing.com - Investing.com Philippines
Is GeneDx Holdings Corp. stock ready for breakoutJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Developing predictive dashboards with GeneDx Holdings Corp. dataJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
What data driven models say about GeneDx Holdings Corp.’s future2025 Trade Ideas & Daily Profit Focused Stock Screening - newser.com
What indicators show strength in GeneDx Holdings Corp.July 2025 Earnings & Precise Buy Zone Identification - newser.com
Is GeneDx Holdings Corp. Equity Warrant still worth holding after the dipJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Market reaction to GeneDx Holdings Corp.’s recent newsWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Using data filters to optimize entry into GeneDx Holdings Corp. Equity WarrantJuly 2025 Intraday Action & Growth Oriented Trade Recommendations - newser.com
Will GeneDx Holdings Corp. Equity Warrant stock continue dividend increases2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - newser.com
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot - MarketScreener
GeneDx upgraded to Buy from Hold on growth outlook - MSN
GeneDx's Blueprint For The Next Healthcare Revolution - Seeking Alpha
FSU’s Landmark Genomics Program Might Change The Case For Investing In GeneDx Holdings (WGS) - Yahoo Finance
GeneDx (WGS): Evaluating Valuation After Landmark Newborn Genomics Contract with Florida State University - Yahoo Finance
Tools to monitor GeneDx Holdings Corp. recovery probabilityWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com
Heatmap analysis for GeneDx Holdings Corp. and competitorsMarket Performance Report & Reliable Breakout Forecasts - newser.com
GeneDx Q2 2025 presentation: revenue jumps 49%, guidance raised on strong results - Investing.com
Earnings call transcript: GeneDx Q2 2025 shows strong revenue growth - Investing.com
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer - Business Wire
Is GeneDx Holdings Corp. Equity Warrant stock attractive for hedge fundsQuarterly Trade Report & Proven Capital Preservation Methods - newser.com
Analyzing GeneDx Holdings Corp. with risk reward ratio chartsQuarterly Profit Review & Low Risk Entry Point Guides - newser.com
Is GeneDx Holdings Corp. stock a safe haven assetEarnings Trend Report & Weekly High Return Forecasts - newser.com
Will GeneDx Holdings Corp. stock maintain growth storyJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Price action breakdown for GeneDx Holdings Corp.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
GeneDx Holdings Corp. stock daily chart insights2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com
Can GeneDx Holdings Corp. stock deliver surprise earnings beat2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program - Business Wire
Legal Advantage Investments Inc. Boosts Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx’s Autism Partnership Program Could Be a Game Changer for GeneDx Holdings (WGS) - Sahm
GeneDx Holdings Corp. Experiences Evaluation Revision Amid Strong Market Performance and Dynamics - Markets Mojo
Is it time to cut losses on GeneDx Holdings Corp.2025 Performance Recap & Consistent Income Trade Ideas - newser.com
Technical signs of recovery in GeneDx Holdings Corp. Equity Warrant2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
Can volume confirm reversal in GeneDx Holdings Corp. Equity Warrant2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Using Python tools to backtest GeneDx Holdings Corp. strategiesQuarterly Investment Review & Real-Time Market Sentiment Alerts - newser.com
Technical analysis overview for GeneDx Holdings Corp. stock2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
Using RSI to spot recovery in GeneDx Holdings Corp.Market Risk Summary & Capital Protection Trade Alerts - newser.com
Top chart patterns to watch in GeneDx Holdings Corp.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics Annual Meeting - MarketScreener
Genedx to launch autism partnership program to expand access to exome and genome testing - MarketScreener
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program - Yahoo Finance
What data driven models say about GeneDx Holdings Corp. Equity Warrant’s futureJuly 2025 Decliners & Community Consensus Picks - newser.com
Genedx Holdings Corp Azioni (WGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Genedx Holdings Corp Azioni (WGS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Option Exercise |
32.67 |
1,246 |
40,707 |
10,001 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Sale |
108.38 |
6,609 |
716,261 |
3,392 |
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):